About Szpital LUX MED
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Szpital LUX MED
During the past decade, Szpital LUX MED conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
2009-10-29
2014-07-09
Completed
361
An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases
2010-09-30
2015-06-30
Completed
210
An Observational Study of Avastin in First Line in Elderly Patients With Metastatic Colorectal Cancer (CASSIOPEE)
2012-03-05
2016-07-20
Completed
402
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
2012-11-27
2020-07-31
Completed
2,185
An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice
2013-07-25
2018-03-20
Completed
279
An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast Cancer
2015-01-14
2016-11-10
Completed
510
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital LUX MED"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Szpital LUX MED
According to Clinical.Site data, the most researched conditions in "Szpital LUX MED" are
"Bone Metastasis" (1 trials), "Cancer" (1 trials), "Cancer Pain" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Szpital LUX MED" in a lesser frequency.
Clinical Trials Intervention Types at Szpital LUX MED
Most popular intervention types in "Szpital LUX MED" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "PF-06650833" (1 trials), "PF-06651600" (1 trials), "Talazoparib" (1 trials), "Tanezumab" (1 trials) and "Tofacitinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Szpital LUX MED
The vast majority of trials in "Szpital LUX MED" are
3 trials for "All" genders.
Clinical Trials Status at Szpital LUX MED
Currently, there are NaN active trials in "Szpital LUX MED".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Szpital LUX MED,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Szpital LUX MED, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".